# New York Blood Center Enterprises – FDA Inspection, Jul 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/9c164be7-dd86-4215-8cb0-e3ba7a8e0d05
Source feed: FDA_Inspections

> FDA inspection 1209368 of New York Blood Center Enterprises, July 06, 2023. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR parts 600 and 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209368
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2023-07-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 12

## Related Documents

- FDA Inspection 983888 - 2016-08-17
- [FDA Inspection 901033 - 2014-10-28](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/2f550a0e-864a-48a9-b402-03154e9b25f7)
- [FDA Inspection 812875 - 2013-01-15](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/26dfa2f6-7368-4e1f-aa5f-703998cdd1ff)
- [FDA Inspection 651951 - 2010-03-23](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/efb67d6e-e903-46bb-8662-9bd709b4ffe7)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/694e089d-d144-4b01-8785-e04f23f49d56

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
